Announcements

25 May 2022

Ad-hoc Announcement: Achiko AG Secures CHF 1.25 million Financing with Strategic Investors Buranto AG and Negma Group

19 May 2022

Ad-hoc Announcement: Achiko AG Reports Key Unaudited Financial Results for the Year Ended 31 December 2021

17 May 2022

Ad-hoc Announcement: Achiko AG Obtains CE Mark for AptameX^TM Covid-19 Rapid Test

29 April 2022

Ad-hoc Announcement: Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 31 May 2022

28 April 2022

Ad-hoc Announcement: AptameX Production and Commercialisation Update

20 April 2022

Ad-hoc Announcement: Achiko AG Signs Major Marketing and Sales Agreement with the World’s Largest Islamic Association for its AptameX Covid-19 rapid test

20 April 2022

Ad-hoc Announcement: Achiko secures up to CHF12m equity and debt financing lines with RiverFort over 3 years

3 March 2022

Ad-hoc Announcement: Achiko AG Production and Sales Update

14 February 2022

Ad-hoc Announcement: Achiko AG Research Paper and Commercialisation Update

27 January 2022

Ad-hoc Announcement: Achiko AG strengthens senior team with appointment of Head of Corporate Development

14 January 2022

Ad-hoc Announcement: Achiko AG Reports Breakthrough Calibration Results for AptameX Covid-19 Rapid Test Technology